Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome
Objective. To evaluate the plasma levels of lnc-DC in primary Sjögren’s syndrome (pSS) patients and investigate the potential associations between lnc-DC and disease activity. Methods. In this study, we recruited 358 enrollments, including 127 pSS patients without immune thrombocytopenia (ITP), 22 p...
Main Authors: | Yanhong Chen, Yongqiang Chen, Beibei Zu, Jia Liu, Li Sun, Chen Ding, Duping Wang, Xing Cheng, DeLiang Yang, Guoping Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/9236234 |
Similar Items
-
Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
by: Li Min, et al.
Published: (2017-03-01) -
Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma
by: Chen Li, et al.
Published: (2015-05-01) -
Post-transcriptional Regulation through Long Noncoding RNAs (lncRNAs)
Published: (2021) -
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides
by: Marco Bocchetti, et al.
Published: (2021-02-01) -
Long Noncoding RNAs as Biomarkers in Cancer
by: Luka Bolha, et al.
Published: (2017-01-01)